Ono Pharmaceutical Co., Ltd. - SWOT Analysis

Datamonitor's Ono Pharmaceutical Co., Ltd. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Ono Pharmaceuticals (Ono) is a pharmaceutical company engaged in production, purchase and sale of pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. The company primarily operates in Japan. It is headquartered in Osaka, Japan and employs about 2,600 people. The company recorded revenues of JPY141,712 million (approximately $1,201.9 million) during the fiscal year ended March 2007, a decrease of 4.7% over 2006. The operating profit of the company was JPY52,841 million (approximately $448.1 million) during fiscal year 2007, a decrease of 7.2% over 2006. The net profit was JPY35,272 million (approximately $299.1 million) in fiscal year 2007, a decrease of 2.4% over 2006. The company has not declared the audited results for the fiscal year 2007 at the time of the publication of the profile.

Scope of the Report

• Provides all the crucial company information required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available